Please Wait.....
Report
United States Artificial Blood Vessels Market Forecast 2024-2032
Market Report I 2024-08-02 I 147 Pages I Inkwood Research
KEY FINDINGS
The United States artificial blood vessels market is projected to develop at a CAGR of 5.81% over the forecast period of 2024-2032. It is set to reach a revenue of $2399.04 million by 2032.
MARKET INSIGHTS
The artificial blood vessels market in the United States is experiencing robust growth, driven by the increasing prevalence of cardiovascular diseases, such as coronary artery disease and peripheral artery disease. These conditions necessitate advanced surgical interventions, including the use of artificial blood vessels for bypass procedures and other vascular treatments. As the demand for these procedures rises, so does the need for innovative and reliable artificial blood vessel solutions that can improve patient outcomes and ensure long-term durability.
Recent developments in the market reflect significant advancements in technology and material science. Innovations such as 3D bioprinting and the incorporation of nanotechnology have revolutionized the production of artificial blood vessels. These technologies enable the creation of customized, patient-specific vascular grafts that closely mimic the properties of natural blood vessels. Additionally, the development of new materials and coatings has enhanced the biocompatibility and functionality of these implants, addressing challenges such as thrombosis and graft failure.
The industry is also witnessing several strategic initiatives aimed at expanding market reach and improving product offerings. Key players are focusing on research and development to introduce modern solutions that cater to various clinical needs. Partnerships and collaborations between medical device manufacturers and research institutions are driving innovation and accelerating the development of advanced artificial blood vessels. These initiatives help address specific challenges in vascular surgery and contribute to the overall growth of the market.
Achieving regulatory approval and meeting high standards for safety and efficacy are crucial goals for manufacturers in the United States. Successfully navigating regulatory requirements, such as those set by the FDA, is essential for market entry and product commercialization. Companies that achieve these milestones demonstrate their commitment to quality and patient safety, which in turn boosts their credibility and market presence.
Hence, the United States artificial blood vessels market is on a positive trajectory, pushed by a combination of rising disease prevalence, technological advancements, and strategic industry initiatives. As the market continues to evolve, ongoing research and innovation will play a pivotal role in addressing the growing demand for effective and durable vascular solutions, ultimately improving patient care and outcomes in the field of cardiovascular health.
SEGMENTATION ANALYSIS
The United States artificial blood vessels market segmentation incorporates the market by type, blood vessel diameter, patient demographics, application, and end-user. The end-user segment is further bifurcated into hospital, specialty clinic, ambulatory surgical center, and other end-users. Hospitals often handle complex and high-volume procedures, including vascular surgeries that require artificial blood vessels. Their extensive infrastructure supports the implementation of cutting-edge technologies and advanced materials, making them key consumers of these products. The demand in this segment is driven by the need for high-quality, reliable artificial blood vessels to treat a wide array of cardiovascular conditions.
Specialty clinic also forms a crucial segment within the end-user category of the artificial blood vessels market. These clinics, which focus on specific areas such as cardiology or vascular surgery, require specialized products tailored to their unique patient needs. The high level of expertise and specialization in these clinics often leads to the use of advanced and customized artificial blood vessels. This segment's growth is fueled by the increasing prevalence of cardiovascular diseases and the rising trend toward specialized, targeted treatment options.
The ambulatory surgical center represents another important end-user segment, catering to outpatient procedures that require artificial blood vessels. ASCs offer a cost-effective and efficient alternative to hospital-based surgeries, focusing on providing high-quality care in a more streamlined setting. The growth in this segment is supported by the increasing preference for minimally invasive procedures and outpatient care, which necessitates the availability of effective and durable artificial blood vessels for a range of vascular interventions.
Other end-users of artificial blood vessels include research institutions, academic medical centers, and home healthcare providers. Research institutions and academic centers contribute to the development and testing of new materials and technologies for artificial blood vessels. Home healthcare providers, on the other hand, may use these products in managing patients with chronic conditions requiring ongoing vascular support. This end-user segment highlights the diverse applications and broadening use cases of artificial blood vessels beyond traditional clinical settings.
COMPETITIVE ANALYSIS
Some of the leading players in the United States artificial blood vessels market include Terumo Medical Corporation, W L Gore & Associates, Artivion Inc, etc.
W L Gore & Associates is a manufacturer of fluoropolymer products with a diverse portfolio spanning multiple industries, including medical devices, industrial manufacturing, electronics, and fabrics. Headquartered in Delaware, United States, the company operates internationally. Renowned for its innovation and high-quality materials, W L Gore & Associates plays a key role in advancing technology and enhancing performance across its various markets. Its commitment to research and development ensures the continuous evolution and improvement of its product offerings.
TABLE OF CONTENTS
1. RESEARCH SCOPE & METHODOLOGY
1.1. STUDY OBJECTIVES
1.2. METHODOLOGY
1.3. ASSUMPTIONS & LIMITATIONS
2. EXECUTIVE SUMMARY
2.1. MARKET SIZE & ESTIMATES
2.2. COUNTRY SNAPSHOT
2.3. COUNTRY ANALYSIS
2.4. SCOPE OF STUDY
2.5. CRISIS SCENARIO ANALYSIS
2.5.1. IMPACT OF COVID-19 ON THE UNITED STATES ARTIFICIAL BLOOD VESSELS MARKET
2.6. MAJOR MARKET FINDINGS
2.6.1. AORTIC DISEASES INCREASE IS SEEN AS A CATALYST FOR MARKET GROWTH
3. MARKET DYNAMICS
3.1. KEY DRIVERS
3.1.1. RISING PREVALENCE OF CARDIOVASCULAR DISEASES AND VASCULAR DISORDERS
3.1.2. ADVANCEMENTS IN TISSUE ENGINEERING AND REGENERATIVE MEDICINE
3.1.3. GROWING GERIATRIC POPULATION AND CHANGING LIFESTYLES
3.2. KEY RESTRAINTS
3.2.1. HIGH COSTS ASSOCIATED WITH THE DEVELOPMENT AND COMMERCIALIZATION OF ARTIFICIAL BLOOD VESSELS
3.2.2. STRINGENT REGULATORY APPROVALS AND CLINICAL TRIAL REQUIREMENTS
3.2.3. CONCERNS REGARDING BIOCOMPATIBILITY AND LONG-TERM DURABILITY
4. KEY ANALYTICS
4.1. KEY MARKET TRENDS
4.1.1. DEVELOPMENT OF 3D BIOPRINTING TECHNIQUES FOR CUSTOMIZED VASCULAR GRAFTS
4.1.2. INCORPORATION OF NANOTECHNOLOGY AND BIOMIMETIC MATERIALS FOR IMPROVED FUNCTIONALITY
4.2. PESTLE ANALYSIS
4.3. PORTER'S FIVE FORCES ANALYSIS
4.3.1. BUYERS POWER
4.3.2. SUPPLIERS POWER
4.3.3. SUBSTITUTION
4.3.4. NEW ENTRANTS
4.3.5. INDUSTRY RIVALRY
4.4. GROWTH PROSPECT MAPPING
4.4.1. GROWTH PROSPECT MAPPING FOR UNITED STATES
4.5. MARKET MATURITY ANALYSIS
4.6. MARKET CONCENTRATION ANALYSIS
4.7. VALUE CHAIN ANALYSIS
4.7.1. RAW MATERIALS
4.7.2. MANUFACTURERS
4.7.3. DISTRIBUTORS
4.7.4. END-USER
4.8. KEY BUYING CRITERIA
4.8.1. BIOCOMPATIBILITY
4.8.2. DURABILITY AND LONGEVITY
4.8.3. CUSTOMIZATION AND VERSATILITY
4.8.4. REGULATORY COMPLIANCE AND QUALITY ASSURANCE
5. MARKET BY TYPE
5.1. EXPANDED POLYTETRAFLUOROETHYLENE (EPTFE)
5.2. POLYETHYLENE TEREPHTHALATE (PET)
5.3. POLYURETHANE
5.4. OTHER TYPES
6. MARKET BY BLOOD VESSEL DIAMETER
6.1. LARGE
6.2. MEDIUM
6.3. SMALL
7. MARKET BY PATIENT DEMOGRAPHICS
7.1. PEDIATRIC
7.2. ADULT
8. MARKET BY APPLICATION
8.1. PERIPHERAL ARTERY
8.2. HEMODIALYSIS
8.3. AORTIC DISEASE
9. MARKET BY END-USER
9.1. HOSPITAL
9.2. SPECIALTY CLINIC
9.3. AMBULATORY SURGICAL CENTER
9.4. OTHER END-USERS
10. COMPETITIVE LANDSCAPE
10.1. KEY STRATEGIC DEVELOPMENTS
10.1.1. MERGERS & ACQUISITIONS
10.1.2. PRODUCT LAUNCHES & DEVELOPMENTS
10.1.3. PARTNERSHIPS & AGREEMENTS
10.1.4. BUSINESS EXPANSIONS & DIVESTITURES
10.2. COMPANY PROFILES
10.2.1. B BRAUN MELSUNGEN AG
10.2.1.1. COMPANY OVERVIEW
10.2.1.2. PRODUCT LIST
10.2.1.3. STRENGTHS & CHALLENGES
10.2.2. BECTON DICKINSON AND COMPANY
10.2.2.1. COMPANY OVERVIEW
10.2.2.2. PRODUCT LIST
10.2.2.3. STRENGTHS & CHALLENGES
10.2.3. TERUMO MEDICAL CORPORATION
10.2.3.1. COMPANY OVERVIEW
10.2.3.2. PRODUCT LIST
10.2.3.3. STRENGTHS & CHALLENGES
10.2.4. W L GORE AND ASSOCIATES
10.2.4.1. COMPANY OVERVIEW
10.2.4.2. PRODUCT LIST
10.2.4.3. STRENGTHS & CHALLENGES
10.2.5. ARTIVION INC
10.2.5.1. COMPANY OVERVIEW
10.2.5.2. PRODUCT LIST
10.2.5.3. STRENGTHS & CHALLENGES
LIST OF TABLES
TABLE 1: MARKET SNAPSHOT - UNITED STATES ARTIFICIAL BLOOD VESSELS
TABLE 2: UNITED STATES ARTIFICIAL BLOOD VESSELS MARKET, BY TYPE, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 3: UNITED STATES ARTIFICIAL BLOOD VESSELS MARKET, BY TYPE, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 4: UNITED STATES ARTIFICIAL BLOOD VESSELS MARKET, BY BLOOD VESSEL DIAMETER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 5: UNITED STATES ARTIFICIAL BLOOD VESSELS MARKET, BY BLOOD VESSEL DIAMETER, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 6: UNITED STATES ARTIFICIAL BLOOD VESSELS MARKET, BY PATIENT DEMOGRAPHICS, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 7: UNITED STATES ARTIFICIAL BLOOD VESSELS MARKET, BY PATIENT DEMOGRAPHICS, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 8: UNITED STATES ARTIFICIAL BLOOD VESSELS MARKET, BY APPLICATION, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 9: UNITED STATES ARTIFICIAL BLOOD VESSELS MARKET, BY APPLICATION, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 10: UNITED STATES ARTIFICIAL BLOOD VESSELS MARKET, BY END-USER, HISTORICAL YEARS, 2018-2022 (IN $ MILLION)
TABLE 11: UNITED STATES ARTIFICIAL BLOOD VESSELS MARKET, BY END-USER, FORECAST YEARS, 2024-2032 (IN $ MILLION)
TABLE 12: LIST OF MERGERS & ACQUISITIONS
TABLE 13: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS
TABLE 14: LIST OF PARTNERSHIPS & AGREEMENTS
TABLE 15: LIST OF BUSINESS EXPANSIONS & DIVESTITURES
LIST OF FIGURES
FIGURE 1: KEY MARKET TRENDS
FIGURE 2: PORTER'S FIVE FORCES ANALYSIS
FIGURE 3: GROWTH PROSPECT MAPPING FOR UNITED STATES
FIGURE 4: MARKET MATURITY ANALYSIS
FIGURE 5: MARKET CONCENTRATION ANALYSIS
FIGURE 6: VALUE CHAIN ANALYSIS
FIGURE 7: KEY BUYING CRITERIA
FIGURE 8: UNITED STATES ARTIFICIAL BLOOD VESSELS MARKET, GROWTH POTENTIAL, BY TYPE, IN 2023
FIGURE 9: UNITED STATES ARTIFICIAL BLOOD VESSELS MARKET, BY EXPANDED POLYTETRAFLUOROETHYLENE (EPTFE), 2024-2032 (IN $ MILLION)
FIGURE 10: UNITED STATES ARTIFICIAL BLOOD VESSELS MARKET, BY POLYETHYLENE TEREPHTHALATE (PET), 2024-2032 (IN $ MILLION)
FIGURE 11: UNITED STATES ARTIFICIAL BLOOD VESSELS MARKET, BY POLYURETHANE, 2024-2032 (IN $ MILLION)
FIGURE 12: UNITED STATES ARTIFICIAL BLOOD VESSELS MARKET, BY OTHER TYPES, 2024-2032 (IN $ MILLION)
FIGURE 13: UNITED STATES ARTIFICIAL BLOOD VESSELS MARKET, GROWTH POTENTIAL, BY BLOOD VESSEL DIAMETER, IN 2023
FIGURE 14: UNITED STATES ARTIFICIAL BLOOD VESSELS MARKET, BY LARGE BLOOD VESSEL, 2024-2032 (IN $ MILLION)
FIGURE 15: UNITED STATES ARTIFICIAL BLOOD VESSELS MARKET, BY MEDIUM BLOOD VESSEL, 2024-2032 (IN $ MILLION)
FIGURE 16: UNITED STATES ARTIFICIAL BLOOD VESSELS MARKET, BY SMALL BLOOD VESSEL, 2024-2032 (IN $ MILLION)
FIGURE 17: UNITED STATES ARTIFICIAL BLOOD VESSELS MARKET, GROWTH POTENTIAL, BY PATIENT DEMOGRAPHICS, IN 2023
FIGURE 18: UNITED STATES ARTIFICIAL BLOOD VESSELS MARKET, BY PEDIATRIC, 2024-2032 (IN $ MILLION)
FIGURE 19: UNITED STATES ARTIFICIAL BLOOD VESSELS MARKET, BY ADULT, 2024-2032 (IN $ MILLION)
FIGURE 20: UNITED STATES ARTIFICIAL BLOOD VESSELS MARKET, GROWTH POTENTIAL, BY APPLICATION, IN 2023
FIGURE 21: UNITED STATES ARTIFICIAL BLOOD VESSELS MARKET, BY PERIPHERAL ARTERY, 2024-2032 (IN $ MILLION)
FIGURE 22: UNITED STATES ARTIFICIAL BLOOD VESSELS MARKET, BY HEMODIALYSIS, 2024-2032 (IN $ MILLION)
FIGURE 23: UNITED STATES ARTIFICIAL BLOOD VESSELS MARKET, BY AORTIC DISEASE, 2024-2032 (IN $ MILLION)
FIGURE 24: UNITED STATES ARTIFICIAL BLOOD VESSELS MARKET, GROWTH POTENTIAL, BY END-USER, IN 2023
FIGURE 25: UNITED STATES ARTIFICIAL BLOOD VESSELS MARKET, BY HOSPITAL, 2024-2032 (IN $ MILLION)
FIGURE 26: UNITED STATES ARTIFICIAL BLOOD VESSELS MARKET, BY SPECIALTY CLINIC, 2024-2032 (IN $ MILLION)
FIGURE 27: UNITED STATES ARTIFICIAL BLOOD VESSELS MARKET, BY AMBULATORY SURGICAL CENTER, 2024-2032 (IN $ MILLION)
FIGURE 28: UNITED STATES ARTIFICIAL BLOOD VESSELS MARKET, BY OTHER END-USERS, 2024-2032 (IN $ MILLION)
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security